Hemmings HC, Rosenberg AD, Reilly CS, Hunter JM.
2010.
The 2010 BJA/PGA supplement: a selection of 10 educational reviews.. Br J Anaesth. 105 Suppl 1:i1-2.
Hemmings HC, Rosenberg AD, Mahajan RP, Webster NR.
2012.
The 2012 BJA/PGA supplement: a selection of seven educational reviews.. Br J Anaesth. 109 Suppl 1:i1-i2.
Hemmings HC, Mantz J.
2008.
Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Hemmings HC, Hunter JM.
2017.
Landmarks in UK anaesthesia.. Br J Anaesth. 119(6):1073-1074.
Hemmings HC, Antognini JF.
2006.
Do general anesthetics add up? Anesthesiology. 104(6):1120-2.
Hemmings HC, Nairn AC, Greengard P.
1986.
Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.
2005.
Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Jevtovic-Todorovic V.
2013.
Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hemmings HC.
1998.
General anesthetic effects on protein kinase C.. Toxicol Lett. 100-101:89-95.
Hemmings HC, Mahajan R, Webster NR.
2016.
The 2016 BJA/PGA special issue: a selection of six educational reviews.. Br J Anaesth. 117(suppl 3):i1-i2.
Hemmings HC, Greengard P.
1986.
DARPP-32, a dopamine-regulated phosphoprotein.. Prog Brain Res. 69:149-59.
Hemmings HC, Riegelhaupt PM, Kelz MB, Solt K, Eckenhoff RG, Orser BA, Goldstein PA.
2019.
Towards a Comprehensive Understanding of Anesthetic Mechanisms of Action: A Decade of Discovery.. Trends Pharmacol Sci. 40(7):464-481.
Hemmings HC.
2004.
Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.